ConductScience.org, home

Paper20028852

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.

Srivastava MK and 4 others. Cancer Res, 2010. Cited by 778 papers, by iCite.

Cite this record

ConductScience Library. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Papers, record 20028852. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20028852

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.
PubMed
Journal
Cancer Res
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
778
iCite
Relative citation ratio, by iCite
16.4
iCite
Revised in PubMed
2025-05-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Srivastava MKMinu K
2Sinha PPratima
3Clements VKVirginia K
4Rodriguez PPaulo
5Ostrand-Rosenberg SSuzanne

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CysteineMajor topic
CystineMajor topic
Lymphocyte ActivationMajor topic
Myeloid CellsMajor topic
T-LymphocytesMajor topic
Amino Acid Transport System y+
Animals
Flow Cytometry
Macrophages
Mice
Mice, Inbred BALB C
Mice, Transgenic
Reverse Transcriptase Polymerase Chain Reaction

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA084232NCI NIH HHSUnited StatesR01CA084232PubMed and NIHNIH RePORTER
R01 CA115880NCI NIH HHSUnited StatesR01CA115880PubMed and NIHNIH RePORTER
R01CA115880NCI NIH HHSUnited StatesR01CA115880PubMed and NIHNIH RePORTER
R01CA84232NCI NIH HHSUnited StatesR01CA084232PubMed and NIHNIH RePORTER

Download CSV of grants

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118792398The thiol redox state of lymphoid organs is modified by immunization: role of different immune cell populations.Eur J Immunol2008https://conductscience.org/library/papers/18792398PubMed
21680678Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T cell clones.Eur J Biochem1991https://conductscience.org/library/papers/1680678PubMed
311983228A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells.J Immunol Methods2002https://conductscience.org/library/papers/11983228PubMed
41632485Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma.Anal Biochem1992https://conductscience.org/library/papers/1632485PubMed
515488763Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis.Cancer Cell2004https://conductscience.org/library/papers/15488763PubMed
615833831Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion.Cancer Res2005https://conductscience.org/library/papers/15833831PubMed
717617589Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response.J Immunol2007https://conductscience.org/library/papers/17617589PubMed
816286925The antioxidant function of the p53 tumor suppressor.Nat Med2005https://conductscience.org/library/papers/16286925PubMed
912974478Cancer vaccines: between the idea and the reality.Nat Rev Immunol2003https://conductscience.org/library/papers/12974478PubMed
1017603493Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.Nat Med2007https://conductscience.org/library/papers/17603493PubMed
1110878351Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation.J Immunol2000https://conductscience.org/library/papers/10878351PubMed
1211295465Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34(+) progenitor cells.Hum Immunol2001https://conductscience.org/library/papers/11295465PubMed
1314652279A prospective study of plasma total cysteine and risk of breast cancer.Cancer Epidemiol Biomarkers Prev2003https://conductscience.org/library/papers/14652279PubMed
1417401668Expression and developmental regulation of the cystine/glutamate exchanger (xc-) in the rat.Neurochem Res2007https://conductscience.org/library/papers/17401668PubMed
1518413722Tumor escape mechanism governed by myeloid-derived suppressor cells.Cancer Res2008https://conductscience.org/library/papers/18413722PubMed
168207197Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression.J Immunol1994https://conductscience.org/library/papers/8207197PubMed
1711792859Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/11792859PubMed
183115975Neutral amino acid transport in mouse peritoneal macrophages.J Biol Chem1987https://conductscience.org/library/papers/3115975PubMed
1918364002Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.Immunol Rev2008https://conductscience.org/library/papers/18364002PubMed
2016339532The role of low molecular weight thiols in T lymphocyte proliferation and IL-2 secretion.J Immunol2005https://conductscience.org/library/papers/16339532PubMed

See all 46 referencesDownload CSV of references

Cited by561

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 778 citations.

PMIDTitleJournalYearIn PapersSource
42941901Metabolic Dysfunction and T-Cell Exhaustion in Colorectal Cancer: Mechanisms, Microenvironment Remodeling, and Therapeutic Opportunities.Int J Mol Sci2026https://conductscience.org/library/papers/42941901PubMed
42903895Nanomaterials Reshaping Tumor Metabolism: A New Frontier to Overcome T Cell Exhaustion.Int J Nanomedicine2026https://conductscience.org/library/papers/42903895PubMed
42878076Selective estrogen receptor degraders and their effect on the breast cancer immune microenvironment.J Clin Invest2026https://conductscience.org/library/papers/42878076PubMed
42812873Myeloid-derived suppressor cells in multiple myeloma: mechanistic insights and therapeutic implications.Front Immunol2026https://conductscience.org/library/papers/42812873PubMed
42757463Arginine metabolism, polyamine homeostasis and ferroptosis in cancer: Molecular links and therapeutic opportunities (Review).Mol Med Rep2026https://conductscience.org/library/papers/42757463PubMed
42738248Myeloid-Mediated Immunoregulation and Resistance to Immune Checkpoint Inhibitor Therapy Across Squamous Cell Carcinomas: Mechanisms and Reprogramming Strategies.Cancers (Basel)2026https://conductscience.org/library/papers/42738248PubMed
42737942The Erk/CREB Signaling Axis Mediates G-CSF-Promoted G-MDSC Survival in the Peripheral Blood of Melanoma-Bearing Mice.Biology (Basel)2026https://conductscience.org/library/papers/42737942PubMed
42713808Monocytic Cell Variations in Postallotransplant Environment: Balancing Graft Versus Host Disease and Graft-Versus-Leukemia Effect.J Immunol Res2026https://conductscience.org/library/papers/42713808PubMed
42630545Technical review of artificial intelligence in TCR-T therapy.J Natl Cancer Cent2026https://conductscience.org/library/papers/42630545PubMed
42608511Cold and hot tumors: immunological determinants, cancer-immunity cycle dysregulation, and nanotechnology-driven therapeutic approaches.Mol Biomed2026https://conductscience.org/library/papers/42608511PubMed
42602393Amino acid metabolic regulatory network in tumor immune escape: mechanistic exploration and intervention directions.Front Immunol2026https://conductscience.org/library/papers/42602393PubMed
42582022Systemic administration of all-trans retinoic acid modulated circulating immune cells but failed to improve healing in a preclinical model of musculoskeletal trauma.Front Immunol2026https://conductscience.org/library/papers/42582022PubMed
42482991Targeting innate immunity to overcome immune evasion in HPV-associated cancers.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42482991PubMed
42458449The role of ferroptosis in the pathogenesis and treatment of breast cancer.J Transl Med2026https://conductscience.org/library/papers/42458449PubMed
42449692Myeloid-Derived Suppressor Cells in Cancer: Metabolic Reprogramming, Immune Crosstalk, and Therapeutic Targeting.Cancers (Basel)2026https://conductscience.org/library/papers/42449692PubMed
42353092Beyond PD-1/PD-L1: Reprogramming the Gynecologic Tumor Microenvironment by Targeting TIGIT and Myeloid Suppression.Int J Mol Sci2026https://conductscience.org/library/papers/42353092PubMed
42346126Myeloid-Derived Suppressor Cells: Function, Migration, and Therapeutic Opportunities in Glioblastoma.Cells2026https://conductscience.org/library/papers/42346126PubMed
42326013Tumor-immune metabolic tug-of-war: from immune escape to targeting metabolic rewiring in cancer therapy.Front Cell Dev Biol2026https://conductscience.org/library/papers/42326013PubMed
42222455Pigmentation-dependent expression of pheomelanogenesis-related genes in human melanoma cells.Postepy Dermatol Alergol2026https://conductscience.org/library/papers/42222455PubMed
42212696Fusobacterium nucleatum in cancer: Interactions with microbiota, tumour colonisation and cancer progression.Clin Transl Med2026https://conductscience.org/library/papers/42212696PubMed

See all 561 cited byDownload CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20028852

GET https://conductscience.org/api/papers/v1/20028852/references?page=2